Crosstalk between macrophages and smooth muscle cells in atherosclerotic vascular diseases

Vascular Pharmacology

Volumn 57, Issue 1, 2012, Pages 24-28

  Koga, Jun ichiro ^a   Aikawa, Masanori ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Atherosclerosis; Macrophages; Smooth muscle cells

Indexed keywords

BRADYKININ B1 RECEPTOR; MACROPHAGE INFLAMMATORY PROTEIN 1; MACROPHAGE INFLAMMATORY PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 1; OXIDIZED LOW DENSITY LIPOPROTEIN; VASCULAR CELL ADHESION MOLECULE 1;

ADIPOCYTE; ATHEROGENESIS; ATHEROSCLEROSIS; CARDIOMETABOLIC RISK; CELL CONTACT; CELL DIFFERENTIATION; CELL INTERACTION; CELL LINEAGE; CELL MIGRATION; CELL PROLIFERATION; DIABETES MELLITUS; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MACROPHAGE; MONOCYTE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SMOOTH MUSCLE FIBER;

ANIMALS; ATHEROSCLEROSIS; CELL COMMUNICATION; HUMANS; MACROPHAGES; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE;

EID: 84862584329     PISSN: 15371891     EISSN: 18793649     Source Type: Journal    
DOI: 10.1016/j.vph.2012.02.011     Document Type: Review

References (46)

1. Aikawa E., Nahrendorf M., Figueiredo J.L., Swirski F.K., Shtatland T., Kohler R.H., Jaffer F.A., Aikawa M., Weissleder R. Osteogenesis associates with inflammation in early-stage atherosclerosis evaluated by molecular imaging in vivo. Circulation 2007, 116:2841-2850.
2. Aikawa E., Nahrendorf M., Sosnovik D., Lok V.M., Jaffer J.A., Aikawa M., Weissleder R. Molecular imaging identifies proteolytic and osteogenic activities in early aortic valve disease. Circulation 2007, 115:377-386.
3. Aikawa E., Aikawa M., Libby P., Figueiredo J.L., Rusanescu G., Iwamoto Y., Fukuda D., Kohler R.H., Shi G.P., Weissleder R. Arterial and aortic valve calcification abolished by elastolytic cathepsin S deficiency chronic renal disease. Circulation 2009, 119:1785-1794.
4. Aikawa M., Sivam P.N., Kuro-o M., Kimura K., Nakahara K., Takewaki S., Ueda M., Yamaguchi H., Yazaki Y., Periasamy M., et al. Human smooth muscle myosin heavy chain isoforms as molecular markers for vascular development and atherosclerosis. Circ. Res. 1993, 73:1000-1012.
5. Aikawa M., Sakomura Y., Ueda M., Kimura K., Manabe I., Ishiwata S., Komiyama N., Yamaguchi H., Yazaki Y., Nagai R. Redifferentiation of smooth muscle cells after coronary angioplasty determined via myosin heavy chain expression. Circulation 1997, 96:82-90.
6. Aikawa M., Rabkin E., Okada Y., Voglic S.J., Clinton S.K., Brinckerhoff C.E., Sukhova G.K., Libby P. Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma: a potential mechanism of lesion stabilization. Circulation 1998, 97:2433-2444.
7. Aikawa M., Rabkin E., Voglic S.J., Shing H., Nagai R., Schoen F.J., Libby P. Lipid lowering promotes accumulation of mature smooth muscle cells expressing smooth muscle myosin heavy chain isoforms in rabbit atheroma. Circ. Res. 1998, 83:1015-1026.
8. Aikawa M., Libby P. The vulnerable atherosclerotic plaque: pathogenesis and therapeutic approach. Cardiovasc. Pathol. 2004, 13:125-138.
9. Chen L., Frister A., Wang S., Ludwig A., Behr H., Pippig S., Li B., Simm A., Hofmann B., Pilowski C., Koch S., Buerke M., Rose-John S., Werdan K., Loppnow H. Interaction of vascular smooth muscle cells and monocytes by soluble factors synergistically enhances IL-6 and MCP-1 production. Am. J. Physiol. Heart Circ. Physiol. 2009, 296:H987-H996.
10. Danenberg H.D., Fishbein I., Epstein H., Waltenberger J., Moerman E., Monkkonen J., Gao J., Gathi I., Reichi R., Golomb G. Systemic depletion of macrophages by liposomal bisphosphonates reduces neointimal formation following balloon-injury in the rat carotid artery. J. Cardiovasc. Pharmacol. 2003, 42:671-679.
11. Deguchi J., Aikawa E., Libby P., Vachon J.R., Inada M., Krane S.M., Whittaker P., Aikawa M. Matrix metalloproteinase-13/collagenase-3 deletion promotes collagen accumulation and organization in mouse atherosclerotic plaques. Circulation 2005, 112:2708-2715.
12. Deguchi J., Huang H., Libby P., Aikawa E., Whittaker P., Sylvan J., Lee R.T., Aikawa M. Genetically engineered collagenase resistance promotes abdominal aortic aneurysm formation in mice infused with angiotensin II. Lab. Invest. 2009, 89:315-326.
13. Egashira K., Nakano K., Ohtani K., Funakoshi K., Zhao G., Ihara Y., Koga J., Kimura S., Tominaga R., Sunagawa K. Local delivery of anti-monocyte chemoattractant protein-1 by gene-eluting stents attenuates in-stent stenosis in rabbits and monkeys. Arterioscler. Thromb. Vasc. Biol. 2007, 27:2563-2568.
14. Ferns G.A., Raines E.W., Sprugel K.H., Motani A.S., Reidy M.A., Ross R. Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science 1991, 253:1129-1132.
15. Fukuda D., Aikawa M. Intimal smooth muscle cells: the context-dependent origin. Circulation 2010, 122:2005-2008.
16. Fukumoto Y., Deguchi J., Libby P., Rabkin E., Sakata Y., Chin M., Hill C.C., Lawler P.R., Varro N., Schoen F.J., Krane S.M., Aikawa M. Genetically-determined resistance to collagenase action augments collagen accumulation in atherosclerotic plaques. Circulation 2004, 110:1953-1959.
17. Fung E., Tang S.T., Canner J.P., Morishige K., Arboleda-Velasquez J.F., Cardoso A.A., Carlesso N., Aster J.C., Aikawa M. Delta-like 4 induces Notch signaling in human macrophages: implications in inflammation. Circulation 2007, 115:2948-2956.
18. Glass C.K., Witztum J.L. Atherosclerosis. The road ahead. Cell 2001, 104:503-516.
19. Gordon S. Macrophage heterogeneity and tissue lipids. J. Clin. Invest. 2007, 117:89-93.
20. Hirata Y., Tabata M., Kurobe H., Motoki T., Akaike M., Nishio C., Higashida M., Mikasa H., Nakaya Y., Takanashi S., Igarashi T., Kitagawa T., Sata M. Coronary atherosclerosis is associated with macrophage polarization in epicardial adipose tissue. J. Am. Coll. Cardiol. 2011, 58:248-255.
21. Hoch J.R., Stark V.K., Hullett D.A., Turnipseed W.D. Vein graft intimal hyperplasia: leukocytes and cytokine gene expression. Surgery 1994, 116:463-470.
22. Holycross B.J., Blank R.S., Thompson M.M., Peach M.J., Owens G.K. Platelet-derived growth factor-BB-induced suppression of smooth muscle cell differentiation. Circ. Res. 1992, 71:1525-1532.
23. Ishibashi M., Hiasa K., Zhao Q., Inoue S., Ohtani K., Kitamoto S., Tsuchihashi M., Sugaya T., Charo I.F., Kura S., Tsuzuki T., Ishibashi T., Takeshita A., Egashira K. Critical role of monocyte chemoattractant protein-1 receptor CCR2 on monocytes in hypertension-induced vascular inflammation and remodeling. Circ. Res. 2004, 94:1203-1210.
24. Iwata H., Manabe I., Fujiu K., Yamamoto T., Takeda N., Eguchi K., Furuya A., Kuro-o M., Sata M., Nagai R. Bone marrow-derived cells contribute to vascular inflammation but do not differentiate into smooth muscle cell lineages. Circulation 2010, 122:2048-2057.
25. Libby P., Aikawa M. Stabilization of atherosclerotic plaques: new mechanisms and clinical targets. Nat. Med. 2002, 8:1257-1262.
26. Mantovani A., Garlanda C., Locati M. Macrophage diversity and polarization in atherosclerosis: a question of balance. Arterioscler. Thromb. Vasc. Biol. 2009, 29:1419-1423.
27. Miyauchi K., Aikawa M., Tani T., Nakahara K., Kawai S., Nagai R., Okada R., Yamaguchi H. Effect of probucol on smooth muscle cell proliferation and dedifferentiation after vascular injury in rabbits: possible role of PDGF. Cardiovasc. Drugs Ther. 1998, 12:251-260.
28. Mooney J.E., Rolfe B.E., Osborne G.W., Sester D.P., van Rooijen N., Campbell G.R., Hume D.A., Campbell J.H. Cellular plasticity of inflammatory myeloid cells in the peritoneal foreign body response. Am. J. Pathol. 2010, 176:369-380.
29. Morisaki N., Koyama N., Kawano M., Mori S., Umemiya K., Koshikawa T., Saito Y., Yoshida S. Human macrophages modulate the phenotype of cultured rabbit aortic smooth muscle cells through secretion of platelet-derived growth factor. Eur. J. Clin. Invest. 1992, 22:461-468.
30. Ni W., Egashira K., Kitamoto S., Kataoka C., Koyanagi M., Inoue S., Imaizumi K., Akiyama C., Nishida K.I., Takeshita A. New anti-monocyte chemoattractant protein-1 gene therapy attenuates atherosclerosis in apolipoprotein E-knockout mice. Circulation 2001, 103:2096-2101.
31. Ohman M.K., Luo W., Wang H., Guo C., Abdallah W., Russo H.M., Eitzman D.T. Perivascular visceral adipose tissue induces atherosclerosis in apolipoprotein E deficient mice. Atherosclerosis 2011, 219:33-39.
32. Owens G.K., Kumar M.S., Wamhoff B.R. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol. Rev. 2004, 84:767-801.
33. Rong J.X., Shapiro M., Trogan E., Fisher E.A. Transdifferentiation of mouse aortic smooth muscle cells to a macrophage-like state after cholesterol loading. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:13531-13536.
34. Roy, C., Marceau, E., Gera, L., François Marceau, F., this issue. An in vitro reconstitution system to address the role of macrophages in the vascular expression of the bradykinin B1 receptor. Vascul. Pharmacol. xxx, xxx-xxx.
35. Saiura A., Sata M., Hirata Y., Nagai R., Makuuchi M. Circulating smooth muscle progenitor cells contribute to atherosclerosis. Nat. Med. 2001, 7:382-383.
36. Shah P.K. Mechanisms of plaque vulnerability and rupture. J. Am. Coll. Cardiol. 2003, 41:15S-22S.
37. Shimizu K., Sugiyama S., Aikawa M., Fukumoto Y., Rabkin E., Libby P., Mitchell R.N. Host bone marrow cells are a source of donor intimal smooth muscle-like cells in murine aortic transplant arteriopathy. Nat. Med. 2001, 7:738-741.
38. Sluimer J.C., Gasc J.M., van Wanroij J.L., Kisters N., Groeneweg M., Sollewijn Gelpke M.D., Cleutjens J.P., van den Akker L.H., Corvol P., Wouters B.G., Daemen M.J., Bijnens A.P. Hypoxia, hypoxia-inducible transcription factor, and macrophages in human atherosclerotic plaques are correlated with intraplaque angiogenesis. J. Am. Coll. Cardiol. 2008, 51:1258-1265.
39. Sugiyama S., Kugiyama K., Nakamura S., Kataoka K., Aikawa M., Shimizu K., Koide S., Mitchell R.N., Ogawa H., Libby P. Characterization of smooth muscle-like cells in circulating human peripheral blood. Atherosclerosis 2006, 187:351-362.
40. Swirski F.K., Libby P., Aikawa E., Alcaide P., Luscinskas F.W., Weissleder R., Pittet M.J. Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata. J. Clin. Invest. 2007, 117:195-205.
41. Takaoka M., Suzuki H., Shioda S., Sekikawa K., Saito Y., Nagai R., Sata M. Endovascular injury induces rapid phenotypic changes in perivascular adipose tissue. Arterioscler. Thromb. Vasc. Biol. 2010, 30:1576-1582.
42. Tatewaki H., Egashira K., Kimura S., Nishida T., Morita S., Tominaga R. Blockade of monocyte chemoattractant protein-1 by adenoviral gene transfer inhibits experimental vein graft neointimal formation. J. Vasc. Surg. 2007, 45:1236-1243.
43. Usui M., Egashira K., Ohtani K., Kataoka C., Ishibashi M., Hiasa K., Katoh M., Zhao Q., Kitamoto S., Takeshita A. Anti-monocyte chemoattractant protein-1 gene therapy inhibits restenotic changes (neointimal hyperplasia) after balloon injury in rats and monkeys. FASEB J. 2002, 16:1838-1840.
44. Veillard N.R., Kwak B., Pelli G., Mulhaupt F., James R.W., Proudfoot A.E., Mach F. Antagonism of RANTES receptors reduces atherosclerotic plaque formation in mice. Circ. Res. 2004, 94:253-261.
45. Wenzel P., Knorr M., Kossmann S., Stratmann J., Hausding M., Schuhmacher S., Karbach S.H., Schwenk M., Yogev N., Schulz E., Oelze M., Grabbe S., Jonuleit H., Becker C., Daiber A., Waisman A., Munzel T. Lysozyme M-positive monocytes mediate angiotensin II-induced arterial hypertension and vascular dysfunction. Circulation 2011, 124:1370-1381.
46. Zhu Y., Hojo Y., Ikeda U., Takahashi M., Shimada K. Interaction between monocytes and vascular smooth muscle cells enhances matrix metalloproteinase-1 production. J. Cardiovasc. Pharmacol. 2000, 36:152-161.